{{Rsnum
|rsid=4771859
|Gene=GPC5
|Chromosome=13
|position=92436398
|Orientation=plus
|GMAF=0.3411
|Gene_s=GPC5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 33.6 | 52.2 | 14.2
| HCB | 57.0 | 37.0 | 5.9
| JPT | 49.1 | 42.0 | 8.9
| YRI | 50.7 | 34.9 | 14.4
| ASW | 38.6 | 50.9 | 10.5
| CHB | 57.0 | 37.0 | 5.9
| CHD | 58.3 | 35.2 | 6.5
| GIH | 40.6 | 49.5 | 9.9
| LWK | 56.4 | 32.7 | 10.9
| MEX | 48.2 | 39.3 | 12.5
| MKK | 43.9 | 47.1 | 9.0
| TSI | 27.5 | 45.1 | 27.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=1E-6
  |OR=1.33
  |ORtxt=[1.088-1.623]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}